Complete response of advanced hepatocellular carcinoma to sorafenib: another case and a comprehensive review

Since sorafenib was introduced in 2007 for treating advanced hepatocellular carcinoma (HCC), 15 patients have achieved a complete response (CR) in advanced HCC. However, only four of these reports can be regarded as real CRs involving adequate assessments including imaging, serum tumor markers, and...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Mol Hepatol
Main Authors: Kim, Tae Suk, Kim, Ji Hoon, Kim, Baek hui, Lee, Young-Sun, Yoo, Yang Jae, Kang, Seong Hee, Suh, Sang-June, Jung, Young Kul, Seo, Yeon Seok, Yim, Hyung Joon, Yeon, Jong Eun, Byun, Kwan Soo
Formato: Artigo
Idioma:Inglês
Publicado em: The Korean Association for the Study of the Liver 2017
Assuntos:
Case Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5760007/
https://ncbi.nlm.nih.gov/pubmed/28633200
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3350/cmh.2016.0070
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados